Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kayla Garzio"'
Autor:
Schonman, Ian, Abraham, Robert, Sterling, Cole Harris, Baran, Kayla Garzio, Schenk, Kara M., Wilbur, H. Catherine, Campbell, Yanka, Chen, Allen Ray Sing, Marrone, Kristen A., Hussaini, S. M. Qasim, Warrier, Govind
Publikováno v:
Journal of Clinical Oncology; 2024 Supplement 10, Vol. 20, p319-319, 19p
Publikováno v:
Journal of Case Reports and Images in Oncology. 9:1-7
Introduction: Cholangiocarcinomas (CCA) are rare, aggressive tumors often diagnosed in advanced stages with limited evidence guiding therapy on progression. Case Report: We report a case of advanced CCA with rapid and aberrant progression, refractory
Publikováno v:
J Neurooncol
PURPOSE: Temozolomide (TMZ), a cytotoxic DNA alkylating agent, is the main chemotherapy used for the treatment of high grade astrocytomas. The active alkylator, methylhydrazine, is not recovered in urine and thus renal function is not expected to aff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072d1cd73c57b5cad563b7ee620d9263
https://europepmc.org/articles/PMC10084787/
https://europepmc.org/articles/PMC10084787/
Autor:
Olga Yankulina, Kelly McElroy, Byram Ozer, Kayla Garzio, Stuart A. Grossman, Matthias Holdhoff
Publikováno v:
Neuro Oncol
BACKGROUND Temozolomide (TMZ) is a cytotoxic DNA alkylating agent. It is the only chemotherapy known to improve survival in patients with high grade astrocytomas. The active alkylating species, methylhydrazine, is not recovered in the urine and thus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cad510d79fc770cd90d81f46e92d0abe
https://europepmc.org/articles/PMC7651152/
https://europepmc.org/articles/PMC7651152/